Blood Coagulation Market Growth, Size, Analysis, Outlook by Trends, Opportunities and Forecast to 2030
Blood Coagulation Testing Market Overview
Blood Coagulation/ Clotting prevents excessive
bleeding during an injury or surgery. Coagulation tests measure blood’s ability
and the duration it takes to clot. These tests help clinicians to assess the
risk of excessive bleeding or developing clots (thrombosis) in the blood
vessels. Clinicians frequently order coagulation tests to assess blood clotting
function in patients before performing surgeries or in treatments of disorders
related to arteries.
Coagulation tests help in determining the probable
bleeding rate in the perioperative or postoperative period. These laboratory
tests are also helpful in elucidating the cause of unexplained bleeding and
predicting blood clotting or thrombosis in the absence of vessel injury. The
global blood coagulation testing market appears to be well-established with the
availability of many well-described assays. The market is growing pervasively
over the past few years. The market is predominantly driven by the rising
prevalence of the liver disease, von Willebrand disease (vWF), and hemophilia
and increasing per capita healthcare expenses. Significant technological
strides in testing devices led by the substantial investments transpired by the
private & public organization are escalating the market on a global level,
driving R&D activities.
According to Market Research Future
(MRFR), the global Blood Coagulation Testing Market is
expected to grow exponentially by 2027. In its recently published study, MRFR
also asserts that the market would register approximately 5.7% CAGR throughout
the assessment period (2020 – 2027). Growing liver failure cases foster market
growth, driving the demand for blood coagulation tests. Well-spread awareness about various diseases and
disorders related to liver, hemophilia, and vWF driven through various
governmental initiatives acts as a major tailwind pushing the growth of the
blood coagulation testing market, further. Additional factors, such as the
increasing population, sedentary lifestyle, and urbanization support market
growth.
Market Segmentation
·
The global market for blood coagulation is
segmented on the basis of product, application, test type, and end user.
·
The products available in the blood coagulation
market are automated testing, clinical laboratory, and semi-automated testing.
·
On the basis of application, the blood
coagulation market has been segmented
into acquired bleeding disorders, hemophilia, congenital bleeding disorders,
and Von Willebrand disease.
·
By test type, the global blood coagulation market has been segmented
into various testing kits and others. Additionally, testing kits are sub-segmented
into activated clotting time, D dimer, and fibrinogen, (FIB prothrombin time
(PT).
·
by end user, the global blood coagulation market
is segmented into academic institutions, diagnostic laboratories, and hospitals.
Regional Analysis
The Americas dominates the global blood coagulation testing
market owing to the increasing patient with liver disease, hemophilia, and von
Willebrand disease (vWF). Additionally, in North America, the early adoption of
advanced technology, increasing government initiatives for research and
development activities, high health care expenditure, and the presence of
several significant companies contribute to the growth of the blood coagulation
market in this region during the evaluation period.
European region accounts for the second largest region in
the global blood coagulation testing market and is likely to maintain its
market share over the evaluation period. The notable growth of the region is
owing to the increasing initiatives and expenditure of the government towards
research and development activities. This is projected to continue to drive the
European market over the forecast period. Additionally, developing countries such
as Germany and France are increasing their investment in the healthcare domain
to improve medical facilities.
The Asia Pacific (APAC) region is the fastest growing blood
coagulation testing market over the assessment
period. This is attributed to the presence of rapidly developing
healthcare technology, expansion of medical infrastructure, a vast patient
populace, and higher healthcare expenditure. Furthermore, increasing demand for
the introduction of new treatment methods in countries like India, Japan, and
South Korea is likely to contribute to the substantial market share over the
review period. Additionally, growing demand for quality devices in the
healthcare is anticipated to increase the adoption of advanced equipment,
which, consequently, is likely to surge the growth of the market in the region
during the forecast period.
the Middle East and Africa (MEA) region is accounted for the
smallest market share over the review period. This is accredited to the
increasing prevalence of blood disorders, which have become a massive problem
owing to ignorance of diseases, lack of consumer awareness, limited screening,
and poor access to treatment. The increase in government initiatives to improve
the healthcare sector to offer necessary medical facilities, expand the
infrastructure, and adopt advanced healthcare technologies, is expected to
contribute substantially to the market share over the evaluation period.
Additionally, the middle eastern developing countries are expected to
contribute to the majority of the market share.
Key Players
The key players acknowledged in the global Blood
Coagulation Testing Market players are Accriva Diagnostics (U.S.A.), Alere
Inc. (U.S.), Bio/Data Corporation (U.S.), CoaguSense, Inc. (U.S.),F.
Hoffmann-La Roche Ltd. (Europe), HomoSonics LLC. (U.S.), iLine Microsystems.
(Europe), Instrumentation Laboratory (U.S.), Siemens Healthcare Private Limited
(Europe), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.).
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment